San Diego stem cell consortium tops in state funding

March 21, 2007

The San Diego Consortium for Regenerative Medicine (SDCRM) leads California in grants and funding following the approval of Comprehensive Research Grants by the state's stem cell agency.

Since late last year, the consortium of UC San Diego, Burnham Institute for Medical Research, Salk Institute for Biological Studies and The Scripps Research Institute has received 29 grants totaling $37,336,063 to conduct life-saving work in human embryonic stem cell research. SDCRM, established in March 2006 as a nonprofit entity, marshals the intellectual resources of four world leaders in life sciences research, bringing scientists from each institution together to conduct joint research and training programs in stem cell research. In the most recent funding round announced Friday, the SDCRM institutes received six grants totaling $16,479,588.

"Our collaborative research at the Consortium will provide the foundation for discoveries offering promise to those suffering from diseases that are currently incurable," said Dr. Edward Holmes, president and CEO of SDCRM and former vice chancellor of Health Sciences at UC San Diego. "The state of California has recognized the extraordinary potential of the San Diego Consortium for Regenerative Medicine by continuing to provide robust support for our efforts."

The latest funding for SDCRM researchers includes two grants received by Burnham Institute. Neurosciences Professor Stuart Lipton will receive $3,035,996 to use human embryonic stem cells to develop a supply of nerve cells for brain repair. Professor Mark Mercola will receive $3,036,002 to develop drug-like molecules that stimulate generation of heart muscle cells from human embryonic stem cells.

UC San Diego scientists received three grants. Larry Goldstein, director of the UC San Diego's Stem Cell Program, will receive $2,512,644 over four years for his work on using human embryonic stem cells to generate human neuronal models of hereditary Alzheimer's disease to help find causes and treatments for the devastating neurological illness. Martin Marsala, UC San Diego professor of anesthesiology at UCSD's School of Medicine, will receive $2,445,716 for using human embryonic stem cells to help treat certain spinal injuries, which may eventually allow improved motor function. UC San Diego biological sciences researcher Yang Xu will receive $2,570,000 for work to promote stable self-renewal of human embryonic stem cells in order to improve scientists' capability to general disease-specific human stem cell lines.

At The Salk Institute, Professor Fred Gage will receive $2,879,210 to develop procedures to induce human embryonic stem cells into mature functioning neurons that carry genes that cause debilitating human neurological diseases. In initial phases of state funding, The Scripps Research Institute received two grants totaling $1,836,280.

SDCRM created its super-partnership to launch new, unprecedented collaborations that will accelerate the development of cures and therapies for some of humanity's most devastating diseases, including Parkinson's and Alzheimer's diseases. The consortium also will expand research and academic efforts in developmental biology, bioinformatics, regenerative medicine ethics, student training and other disciplines.

"Of all the California research teams funded by Prop. 71 dollars, only the SDCRM offers a partnership of preeminent nonprofit research institutions," Holmes said. "With these four renowned institutions working together, we can provide a synergy of scientific collaboration that's not possible at individual institutions."

Funding is from Proposition 71, the Stem Cell Research and Cures Act, which California voters approved in 2004 to provide $3 billion in stem cell research. Grants are approved by the 29-member Independent Citizens Oversight Committee (ICOC), governing board of the California Institute for Regenerative Medicine (CIRM).

In the first round of funding, SDCRM received $13.4 million to support 19 research projects. The initial funds are known as the Leon Thal SEED grants, named for the renowned UCSD Alzheimer's researcher who died in February.
-end-


University of California - San Diego

Related Regenerative Medicine Articles from Brightsurf:

Stem cells: new insights for future regenerative medicine approaches
The study published in Open Biology unravels important data for a better understanding of the process of division in stem cells and for the development of safer ways to use them in medicine.

Engineered developmental signals could illuminate regenerative medicine
For a tiny embryo to develop into an adult organism, its cells must develop in precise patterns and interact with their neighbors in carefully orchestrated ways.

A new discovery in regenerative medicine
An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.

New research into stem cell mutations could improve regenerative medicine
Research from the University of Sheffield has given new insight into the cause of mutations in pluripotent stem cells and potential ways of stopping these mutations from occurring.

Keratin scaffolds could advance regenerative medicine and tissue engineering for humans
Researchers at Mossakowski Medical Research Center of the Polish Academy of Science have developed a simple method for preparing 3D keratin scaffold models which can be used to study the regeneration of tissue.

NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.

A new material for regenerative medicine capable to control cell immune response
Scientists of Tomsk Polytechnic University jointly with the University of Montana (USA) proposed a new promising material for regenerative medicine for recovery of damaged tissues and blood vessels.

Optoceutics: A new technique using light for regenerative medicine
Researchers in Italy at IIT-Istituto Italiano di Tecnologia used visible light together with photo-sensitive and biocompatible materials to facilitate the formation of new blood vessels in vitro.

Major stem cell discovery to boost research into development and regenerative medicine
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells.

Spinning-prism microscope helps gather stem cells for regenerative medicine
Pluripotent stem cells are crucial to regenerative medicine, but better screening methods are needed to isolate safe and effective cells for medical use.

Read More: Regenerative Medicine News and Regenerative Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.